Loading clinical trials...
Loading clinical trials...
The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Metabiomics Corp
NCT06885697 · Mesothelioma, Neoplasms, and more
NCT05789433 · Colonic Neoplasms, Rectal Neoplasms
NCT06121089 · Colonic Neoplasms Malignant, Cecal Neoplasms
NCT00579163 · Breast Neoplasms, Ovarian Neoplasms, and more
NCT05500248 · Colonic Neoplasms
University of Colorado School of Medicine Anschutz Medical Campus
Aurora, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions